The Icelandic-Danish startup company ArcanaBio has joined the Danish Quantum Community as a new partner.
ArcanaBio specializes in nano-photonics and biosensors. The company is focused on developing innovative liquid biopsy agnostic solutions that enable comprehensive health diagnostics. The goal is to provide faster, more affordable, high-frequency detection capabilities – with focus on everyday use for long term biomarker measurements.
In September of 2024, ArcanaBio secured funding from Denmark’s BioInnovation Institute (BII), supported by the Novo Nordisk Foundation, and joined BII’s Deep Tech Lab – Quantum (DTL-Q) program in Copenhagen. The Deep Tech Lab is Denmark’s official NATO DIANA accelerator site, driving innovation of dual-use technology in the life science and defense industries. At DTL-Q, ArcanaBio is working alongside other high-tech companies on the cutting-edge technologies of tomorrow.
ArcanaBio’s current projects involve combining novel quantum based sensing technologies and AI for diagnostic applications as well as research, to further advance the company’s new platform. ArcanaBio has already secured a first-of-a-kind collaboration agreement with the University Hospital of Iceland – Department of Microbiology.
We look forward to strengthening the Danish quantum ecosystem together.
About
Read more about ArcanaBio here.
Photo credentials: Esben Zøllner Olesen for BioInnovation Institute
